<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02548104</url>
  </required_header>
  <id_info>
    <org_study_id>CSMCPro00034213</org_study_id>
    <nct_id>NCT02548104</nct_id>
    <nct_alias>NCT02167282</nct_alias>
  </id_info>
  <brief_title>Analgesic Efficacy of Anterior Femoral, Genicular and Adductor Canal Nerve Block</brief_title>
  <official_title>Department of Anesthesiology of Cedars Sinai Medical Center</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cedars-Sinai Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cedars-Sinai Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recently, more distal approach to femoral nerve branches (saphenous) in the adductor canal in
      the medial compartment of the thigh have shown to provide comparable anesthesia and analgesia
      without quadriceps muscle weakness than traditional femoral nerve blocks (FNB) after total
      knee arthroplasty (TKA). Adductor canal block (ACB) has the unique advantage of providing
      localized analgesia to the peripatellar and intra-articular aspects of the knee joint without
      reducing the patient's ability to perform a straight leg raise. However, it does not
      adequately address the incisional pain component on the anterior surface of the knee
      innervated by anterior femoral cutaneous nerve. This pain may be improved by addition of the
      anterior femoral block (AFB). Additionally, the ACB does not provide analgesia to the
      posterior aspect of the knee, which is commonly moderate to severe after surgery. This pain
      may be decreased by addition of the genicular block, also known as the iPACK block
      (interspace between the popliteal artery and the capsule of the knee). There is no study that
      has evaluated the potentially analgesic benefits of the AFB or the iPACK block combined with
      ACB after TKA. Therefore, the investigators designed this randomized, prospective, and
      double-blinded study to assess our hypothesis that the addition of the AFB and/or iPACK block
      to the ACB will improve analgesic effects, decrease pain scores, deceased opioid requirement,
      and as well as facilitate early recovery and improve patient satisfaction with pain
      management in patient after TKA.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2017</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes of pain scores (VRS) at rest</measure>
    <time_frame>Post-op day 1,2,3</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes of pain scores (VRS) at motion activity</measure>
    <time_frame>Post-op day 1,2,3</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction score(0-very dissatisfied to 10 very satisfied)</measure>
    <time_frame>Post-op day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction score (0-very dissatisfied to 10 very satisfied)</measure>
    <time_frame>Post-op day 2</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction score (0-very dissatisfied to 10 very satisfied)</measure>
    <time_frame>Post-op day 3</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gait distance (feet)</measure>
    <time_frame>Post-op day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gait distance (feet)</measure>
    <time_frame>Post-op day 2</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gait distance (feet)</measure>
    <time_frame>Post-op day 3</time_frame>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">144</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Adductor canal block (ACB)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Group I Adductor canal block (ACB): 0.25% bupivacaine with 1:200,000 epinephrine 30 ml Anterior Femoral Block (AFB): Saline 15 ml Interspace between the popliteal artery and the capsule of the knee (iPACK) block: Saline 15 ml</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ACB + AFB</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group I I Adductor canal block (ACB): 0.25% bupivacaine with 1:200,000 epinephrine 30 ml Anterior Femoral Block (AFB): 0.25% bupivacaine with 1:200,000 epinephrine 15 ml Interspace between the popliteal artery and the capsule of the knee (iPACK) block: Saline 15 ml</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ACB + iPACK</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group III Adductor canal block (ACB): 0.25% bupivacaine with 1:200,000 epinephrine 30 ml Anterior Femoral Block (AFB): Saline 15 ml Interspace between the popliteal artery and the capsule of the knee (iPACK) block: 0.25% Bupivicaine with 1:200,000 epinephrine 15 ml</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ACB + AFB + iPACK</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Group IV Adductor canal block (ACB): 0.25% bupivacaine with 1:200,000 epinephrine 30 ml Anterior Femoral Block (AFB): 0.25% bupivacaine with 1:200,000 epinephrine 15 ml Interspace between the popliteal artery and the capsule of the knee (iPACK) block: 0.25% Bupivicaine with 1:200,000 epinephrine 15 ml</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ACB</intervention_name>
    <description>Before surgery, Adductor canal block (ACB): 0.25% Bupivacaine with 1:200,000 epinephrine 30 ml Anterior Femoral Block (AFB): Saline 15 ml Interspace between the popliteal artery and the capsule of the knee (iPACK) block: Saline 15 ml</description>
    <arm_group_label>ACB + AFB</arm_group_label>
    <arm_group_label>ACB + iPACK</arm_group_label>
    <arm_group_label>ACB + AFB + iPACK</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ACB + AFB</intervention_name>
    <description>Before the surgery, Adductor canal block (ACB): 0.25% Bupivacaine with 1:200,000 epinephrine 30 ml Anterior Femoral Block (AFB): 0.25% Bupivacaine with 1:200,000 epinephrine 15 ml Interspace between the popliteal artery and the capsule of the knee (iPACK) block: Saline 15 ml</description>
    <arm_group_label>Adductor canal block (ACB)</arm_group_label>
    <arm_group_label>ACB + iPACK</arm_group_label>
    <arm_group_label>ACB + AFB + iPACK</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ACB + iPACK</intervention_name>
    <description>Before the surgery, Adductor canal block (ACB): 0.25% Bupivacaine with 1:200,000 epinephrine 30 ml Anterior Femoral Block (AFB): Saline 15 ml Interspace between the popliteal artery and the capsule of the knee (iPACK) block: 0.25% Bupivicaine with 1:200,000 epinephrine 15 ml</description>
    <arm_group_label>Adductor canal block (ACB)</arm_group_label>
    <arm_group_label>ACB + AFB</arm_group_label>
    <arm_group_label>ACB + AFB + iPACK</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ACB + AFB+ iPACK</intervention_name>
    <description>Before the surgery, Adductor canal block (ACB): 0.25% Bupivacaine with 1:200,000 epinephrine 30 ml Anterior Femoral Block (AFB): 0.25% Bupivacaine with 1:200,000 epinephrine 15 ml Interspace between the popliteal artery and the capsule of the knee (iPACK) block: 0.25% Bupivicaine with 1:200,000 epinephrine 15 ml</description>
    <arm_group_label>Adductor canal block (ACB)</arm_group_label>
    <arm_group_label>ACB + AFB</arm_group_label>
    <arm_group_label>ACB + iPACK</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age 18-90 yrs

          2. The American Society of Anesthesiologists (ASA) Physical Status 1-3

          3. Either gender

        Exclusion Criteria:

          1. Refusal to participate in the study

          2. Age&lt; 18 yrs, or&gt; 90 yrs

          3. General anesthesia

          4. Bilateral TKA, or revision of TKA

          5. Contraindications to regional blockage including but not limited to:

               -  Patient refusal to regional blockade

               -  Infection at the site of needle insertion

               -  Systemic infection

               -  Bleeding diathesis or coagulopathy (as diagnosed by history or laboratory
                  evaluation)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roya Yumul, M.D.,PhD.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Roya Yumul, M.D.,PhD.</last_name>
    <phone>310-423-5841</phone>
    <email>Roya.Yumul@cshs.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jun Tang, M.D.</last_name>
    <phone>310-423-5841</phone>
    <email>tangfriend@yahoo.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cedars Sinai Medical Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roya Yumul, M.D., PhD.</last_name>
      <phone>310-423-5841</phone>
      <email>Roya.Yumul@cshs.org</email>
    </contact>
    <contact_backup>
      <last_name>Jun Tang, M.D.</last_name>
      <phone>310-423-5841</phone>
      <email>tangfriend@yahoo.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 8, 2015</study_first_submitted>
  <study_first_submitted_qc>September 11, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 14, 2015</study_first_posted>
  <last_update_submitted>January 23, 2018</last_update_submitted>
  <last_update_submitted_qc>January 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cedars-Sinai Medical Center</investigator_affiliation>
    <investigator_full_name>Roya Yumul, M.D.,PhD.</investigator_full_name>
    <investigator_title>Department of anesthesiology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

